Effects of Pentoxifylline on Non-Alcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial in Iran

BACKGROUND: Non-alcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease. Several studies suggest that pentoxifylline (PTX) can improve the disease outcome. OBJECTIVES: We aimed to compare the effect of pentoxifylline with placebo on liver aminotransferases and cyto...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Hepat Mon
Главные авторы: Baniasadi, Nadieh, Salajegheh, Faranak, Pardakhty, Abbas, Seyedmirzaee, Seyed Mehdi, Hayatbakhsh, Mohammad Mahdi, Nikpoor, Amin Reza, Mohammadi, Mojgan
Формат: Artigo
Язык:Inglês
Опубликовано: Kowsar 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4719129/
https://ncbi.nlm.nih.gov/pubmed/26834792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.32418
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы